For example, pegvisomant, a growth hormone receptor antagonist, is used for normalizing IGF-1 levels in acromegaly [97] and teprotumumab, which antagonizes IGF-1R, is used to treat thyroid eye disease [98]. The gene discussed is IGF1R; the disease is acromegaly.